Sanofi (SNY) Minority Interest (2009 - 2026)

Sanofi has disclosed Minority Interest across 18 years of filings, most recently posting $418.5 million for Q2 2026.

• In Q2 2026, Minority Interest rose 36.41% year-over-year to $418.5 million; the TTM figure through Jun 2026 stood at $418.5 million (up 36.41% YoY), while the FY2025 annual figure was $388.8 million, up 2.63% from the prior year.
• Minority Interest came in at $418.5 million for Q2 2026 at Sanofi, up from $388.8 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $418.5 million in Q2 2026 to a low of $306.8 million in Q2 2025.
• Average Minority Interest over 5 years is $361.5 million, with a median of $374.0 million recorded in 2024.
• Year-over-year, Minority Interest soared 146.28% in 2022 and retreated 10.3% in 2023.
• Over 5 years, Minority Interest stood at $375.5 million in 2022, then dropped by 10.3% to $336.8 million in 2023, then climbed by 11.06% to $374.0 million in 2024, then climbed by 3.95% to $388.8 million in 2025, then rose by 7.63% to $418.5 million in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were $418.5 million in Q2 2026, $388.8 million in Q4 2025, and $306.8 million in Q2 2025.